Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study
-
* Corresponding author: Karen A Gelmon kgelmon@bccancer.bc.ca
Breast Cancer Research 2008, 10:R6 doi:10.1186/bcr1847
See related editorial by Brennan and Gallagher, http://breast-cancer-research.com/content/10/1/102
No comments have yet been made on this article.